Eur Respir J 1990; 3: 606-607
Copyright © ERS Journals Ltd 1990
Pulmonary hypertension and fenfluramine
HM Pouwels,
JL Smeets,
EC Cheriex,
and
EF Wouters
Fenfluramine is a widely prescribed anorectic drug as adjuvant therapy for obesity. Pulmonary vascular hypertension after use of fenfluramine is rarely reported. We present a patient with pulmonary hypertension and right heart failure after treatment with fenfluramine. Pulmonary hypertension resolved after withdrawal of the drug.
This article has been cited by other articles:

|
 |

|
 |
 
V. Setola, M. Dukat, R. A. Glennon, and B. L. Roth
Molecular Determinants for the Interaction of the Valvulopathic Anorexigen Norfenfluramine with the 5-HT2B Receptor
Mol. Pharmacol.,
July 1, 2005;
68(1):
20 - 33.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Rich, L. Rubin, A. M. Walker, S. Schneeweiss, and L. Abenhaim
Anorexigens and Pulmonary Hypertension in the United States: Results From the Surveillance of North American Pulmonary Hypertension
Chest,
March 1, 2000;
117(3):
870 - 874.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. M. TUDER, Z. RADISAVLJEVIC, K. R. SHROYER, J. M. POLAK, and N. F. VOELKEL
Monoclonal Endothelial Cells in Appetite Suppressant-associated Pulmonary Hypertension
Am. J. Respir. Crit. Care Med.,
December 1, 1998;
158(6):
1999 - 2001.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
U. D. McCann, L. S. Seiden, L. J. Rubin, and G. A. Ricaurte
Brain Serotonin Neurotoxicity and Primary Pulmonary Hypertension From Fenfluramine and Dexfenfluramine: A Systematic Review of the Evidence
JAMA,
August 27, 1997;
278(8):
666 - 672.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
E. K. Weir, H. L. Reeve, J. M.C. Huang, E. Michelakis, D. P. Nelson, V. Hampl, and S. L. Archer
Anorexic Agents Aminorex, Fenfluramine, and Dexfenfluramine Inhibit Potassium Current in Rat Pulmonary Vascular Smooth Muscle and Cause Pulmonary Vasoconstriction
Circulation,
November 1, 1996;
94(9):
2216 - 2220.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
L. Abenhaim, Y. Moride, F. Brenot, S. Rich, J. Benichou, X. Kurz, T. Higenbottam, C. Oakley, E. Wouters, M. Aubier, et al.
Appetite-Suppressant Drugs and the Risk of Primary Pulmonary Hypertension
N. Engl. J. Med.,
August 29, 1996;
335(9):
609 - 616.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. A. Stahl and T. F. Imperiale
An Overview of the Efficacy and Safety of Fenfluramine and Mazindol in the Treatment of Obesity
Arch Fam Med,
October 1, 1993;
2(10):
1033 - 1038.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Hirsch
Barriers to Treating Obesity
Ann Intern Med,
October 15, 1991;
115(8):
656 - 657.
[Abstract]
[PDF]
|
 |
|
Copyright © 1990 by the European Respiratory Society.
|